Applied genetic technologies corporation.

Applied Genetic Technologies Corporation 2013 Employee Stock Purchase Plan (Full titles of plans) Susan B. Washer . President and Chief Executive Officer . Applied Genetic Technologies Corporation . 14193 NW 119th Terrace, Suite 10 . Alachua, Florida 32615 (386) 462-2204On June 7, 2022, Applied Genetic Technologies Corporation (the "Company") received written notice from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company is not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Global Market, as set forth in Listing Rule 5450(a)(1).A high-level overview of Applied Genetic Technologies Corporation (AGTC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Follow. Dublin, June 28, 2021 (GLOBE NEWSWIRE) -- The "Gene Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The ...

21 Feb 2022 Applied Genetic Technologies Corporation plans toxicology and biodistribution studies, in 2022 ; Subscriber content You need to be a logged in subscriber to view this content. If your organization has a subscription then there are several options available to help you access AdisInsight, even while ...Applied Genetic Technologies Corporation T: (617) 843-5728 [email protected]. Stephen Potter Chief Business Officer Applied Genetic Technologies Corporation T: (617) 413-2754

Aug 19, 2021 · Applied Genetic Technologies Corporation T: (617) 413-2754 [email protected] ... AGTC and Otonomy each disclaim any obligation to update any forward-looking statements, except as required by law. AGTC Contacts: IR/PR Contacts: David Carey (IR) or Tom Vickery (PR) Lazar ...

14193 NW 119th Terrace. Suite 10. Alachua, Florida, 32165 (Address of principal executive offices) (Zip Code) (386) 462-2204 (Registrant’s telephone number, including area code)Applied Genetic Technologies Corporation (AGTC) is developing a recombinant adeno-associated virus (rAAV) vector AGTC-501, also designated rAAV2tYF-GRK1-hRPGRco, to treat X-linked retinitis pigmentosa (XLRP) in patients with mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene.The vector contains a codon-optimized …APPLIED GENETIC TECHNOLOGIES CORP : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc ...Dec 1, 2022 · Introductory Note As previously disclosed on a Form 8-K filed with the Securities and Exchange Commission ("SEC") on October 24, 2022, Applied Genetics Technology Corporation, a Delaware corporation (the "Company "), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Alliance Holdco Limited, a private limited company organized under the laws of England and Wales (the ...

Nov 3, 2022 · Applied Genetic Technologies Corporation Contacts: IR Contact: David Carey Lazar FINN Partners T: (212) 867-1768 [email protected]. Corporate Contact: Jonathan Lieber Chief Financial ...

Applied Genetic Technologies Corporation Contacts: IR Contact: David Carey Lazar FINN Partners T: (212) 867-1768 [email protected]. Corporate Contact: Jonathan Lieber

Applied Genetic Technologies is not a large company by global standards. It has a market capitalization of US$122m, which means it wouldn't have the attention of many institutional investors.May 13, 2021 · GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno ... Jul 13, 2022 · GAINESVILLE, Fla., and CAMBRIDGE, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), a clinical-stage biotechnology ... Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company uses gene therapy platform to develop genetic …Contact Data PR Contact: Kerry Sinclair Spectrum Science Communications Corporate Contact: Jonathan Lieber Chief Financial Officer Applied Genetic Technologies Corporation T: (617) 843-5778Applied Genetic Technologies Corp: ClinicalTrials.gov Identifier: NCT02416622 Other Study ID Numbers: AGTC-RS1-001 : First Posted: April 15, 2015 Key Record Dates: Results First Posted: July 1, 2020: Last Update Posted: June 12, 2023 Last Verified: June 2023

Applied Genetic Technologies Corp. published this content on 30 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 March 2022 18:24:09 UTC.APPLIED GENETIC TECHNOLOGIES CORPORATION: BALANCE SHEETS (Unaudited) September 30, June 30, In thousands, except per share data 2020 …Applied Genetic Technologies Corporation (AGTC) reported positive 3-month interim data from its ongoing phase 2 Skyline trial of AGTC-501, a recombinant …Applied Genetic Technologies Corporation T: (617) 843-5728 [email protected]. Stephen Potter Chief Business Officer Applied Genetic Technologies Corporation T: (617) 413-2754A high-level overview of Applied Genetic Technologies Corporation (AGTC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Last Updated: 24-Oct-2022. Syncona Limited, a leading healthcare company focused on founding, building and funding global leaders in life science, today announces that its …Applied Genetic Technologies Corporation (Nasdaq: AGTC) (“AGTC” or the “Company”) and a newly established portfolio company of Syncona Limited (“Syncona”), a leading healthcare company focused on founding, building and funding global leaders in life science, announced the commencement today of the previously announced tender offer ...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a …

APPLIED GENETIC TECHNOLOGIES CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware : 59-3553710 (State or Other Jurisdiction of. Incorporation or Organization) (I.R.S. Employer. Identification No.) 14193 NW 119 th Terrace, Suite 10, Alachua, Florida 32615GAINESVILLE, Fla. and CAMBRIDGE, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), a clinical-stage biotechnology ...GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 23, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a …Applying for a job can be an overwhelming process, especially when it comes to online applications. With the rise of technology, many companies, including popular retailers like Ackermans, have moved their application processes online.GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a …Oct 26, 2022 · Applied Genetic Technologies Corporation Contacts: IR Contact: David Carey Lazar FINN Partners T: (212) 867-1768 [email protected]. Corporate Contact: Jonathan Lieber Applied Genetic Technologies Corporation . 14193 NW 119 th Terrace, Suite 10 . Alachua, Florida 32615 (386) 462-2204 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications . on Behalf of the Person(s) Filing Statement) With copies to:14193 NW 119th Terrace. Suite 10. Alachua, Florida, 32165 (Address of principal executive offices) (Zip Code) (386) 462-2204 (Registrant’s telephone number, including area code)

Syncona to acquire Applied Genetic Technologies Corporation. London investment fund Syncona will acquire retinal gene therapy company Applied Genetic Technologies Corporation (AGTC): …

Dec 1, 2022 · Introductory Note As previously disclosed on a Form 8-K filed with the Securities and Exchange Commission ("SEC") on October 24, 2022, Applied Genetics Technology Corporation, a Delaware corporation (the "Company "), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Alliance Holdco Limited, a private limited company organized under the laws of England and Wales (the ...

Applied Genetic Technologies Corporation (NASDAQ: AGTC) is a Florida based clinical stage biotech concern. The company is focused on developing transformational genetic therapies for patients ...Presentation Date/Time: July 16, 2022; 3:57 PM – 4:03 PM ET. Sub-retinal Gene Therapy Drug AGTC-501 for X-Linked Retinitis Pigmentosa Phase 2 Randomized, Controlled, Masked Multicenter Clinical ...GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno ...The new portfolio company has been created by Syncona through the combination of Applied Genetic Technologies Corporation’s (AGTC’s) late-stage programme in X-linked retinitis pigmentosa (XLRP), …GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno ...GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical stage biotechnology company focused on the development ...Applied Genetic Technologies Corporation (AGTC) is developing a recombinant adeno-associated virus (rAAV) vector AGTC-501, also designated AAV2tYF-GRK1-RPGRco, to treat retinitis pigmentosa (RP) in patients with mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene. Corporate Contact: Stephen Potter. Chief Business Officer. Applied Genetic Technologies Corporation. T: (617) 413-2754. [email protected]. - AGTC Welcomes Susan Schneider as the Chief Medical ...GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today that a ...October 24, 2022. Venture firm Syncona is acquiring Applied Genetic Technologies Corporation, a company focused on the development and commercialization of adeno-associated virus-based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal diseases, for approximately $23.5 million plus ...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of ...APPLIED GENETIC TECHNOLOGIES CORPORATION CONDENSED BALANCE SHEETS (Unaudited) In thousands. December 31, 2021. June 30, 2021. ASSETS. Current assets: Cash and cash equivalents $ 72,771 $ 105,052.Applied Genetic Technologies Corporation T: (617) 413-2754 [email protected] ...Instagram:https://instagram. dvn nysetop unregulated forex brokerslegalshield vs aragreadback APPLIED GENETIC TECHNOLOGIES CORP : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc ... trading forex on thinkorswimzscaler market cap Applied Genetic Technologies Corporation (AGTC) is developing a recombinant adeno-associated virus (rAAV) vector AGTC-501, also designated AAV2tYF-GRK1-RPGRco, to treat retinitis pigmentosa (RP) in patients with mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene. Dec 1, 2022 · Introductory Note As previously disclosed on a Form 8-K filed with the Securities and Exchange Commission ("SEC") on October 24, 2022, Applied Genetics Technology Corporation, a Delaware corporation (the "Company "), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Alliance Holdco Limited, a private limited company organized under the laws of England and Wales (the ... meta stock Aug 19, 2021 · Applied Genetic Technologies Corporation T: (617) 413-2754 [email protected] ... GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 23, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a …1. Purpose.The Applied Genetic Technologies Corporation Stock Option Plan (the “Plan”) is established to create an additional incentive for key employees, directors and consultants or advisors of Applied Genetic Technologies Corporation and any successor corporations thereto (collectively referred to as the “Company”), and any present or future parent …